According to Greek mythology, “the wound that would not heal” was inflicted by the intemperate warrior Achilles when he fell upon Telephus, son of Hercules, after invading an allied kingdom in the mistaken belief that he had landed at Troy. Terrible... Read more »
Scientists have tried for decades to coax the body’s immune system to hunt down and kill cancer cells, much in the same way it fights viruses and bacteria. The idea has always been to create a standard treatment against tumors that’s... Read more »
Tired of turkey? Have some Thanksgiving leftovers from Seattle tech: Rudy Gadre is joining Founder’s Co-op as a partner; 2013 Techstars companies Wire and Inside Social got investors’ attention; Indow Windows also raised new capital; Point Inside launched an interesting new... Read more »
Landing the right introductions can change the fortunes of startups.
That can mean getting a big-name customer or finding the perfect developer to join the team. But making that first, important contact is a challenge for many founders.
To tackle this,... Read more »
It happens to me all the time. I’m scrolling through Facebook feeds or Pinterest boards only to see an item of clothing or a plate of food (ok, usually food) that makes me think, “Must. Have. Now!”
Pavo, a new... Read more »
Biodesix, a medical diagnostics startup based in Boulder, CO, has raised an $8.3 million Series E round, the company announced Monday. The round included $4.3 million in new funds from existing investors and the conversion of a $4 million convertible... Read more »
After 13 years at the helm of SomaLogic, a Boulder, CO-based startup developing diagnostic tests that use protein biomarkers to identify maladies, Larry Gold is stepping down as CEO, the company announced Tuesday.
Gold founded SomaLogic in 2000 and has... Read more »
It’s not every startup that gets a Twitter endorsement from MC Hammer.
But that’s the sort of year it’s been for Houston-based Rebellion Photonics, which makes a real-time hyperspectral camera that can detect poisonous or potentially explosive gas leaks from oil... Read more »
OncoMed Pharmaceuticals (NASDAQ: OMED) may be a long ways away from actually winning FDA approval of a product, but it just got a big vote of confidence from Celgene that it’s on the right track with its cancer stem cell... Read more »